Found: 41
Select item for more details and to access through your institution.
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00888-y
- By:
- Publication type:
- Article
Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1332157
- By:
- Publication type:
- Article
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 3, p. 644, doi. 10.1093/infdis/jiad472
- By:
- Publication type:
- Article
B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 1, p. 1, doi. 10.3390/v16010001
- By:
- Publication type:
- Article
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1270908
- By:
- Publication type:
- Article
Antiviral Potential of Azelastine against Major Respiratory Viruses.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 12, p. 2300, doi. 10.3390/v15122300
- By:
- Publication type:
- Article
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41049-4
- By:
- Publication type:
- Article
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1196988
- By:
- Publication type:
- Article
Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV2 mRNA or vector vaccine.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 1, p. e17, doi. 10.1515/cclm-2022-0787
- By:
- Publication type:
- Article
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35312-3
- By:
- Publication type:
- Article
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 11, p. 1909, doi. 10.1093/infdis/jiac379
- By:
- Publication type:
- Article
miR-142 favors naïve B cell residence in peripheral lymph nodes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.847415
- By:
- Publication type:
- Article
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/v14102294
- By:
- Publication type:
- Article
Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 39, p. 16, doi. 10.2807/1560-7917.ES.2022.27.39.2101027
- By:
- Publication type:
- Article
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 8, p. 1642, doi. 10.3390/v14081642
- By:
- Publication type:
- Article
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.861295
- By:
- Publication type:
- Article
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion.
- Published in:
- EMBO Reports, 2022, v. 23, n. 6, p. 1, doi. 10.15252/embr.202154305
- By:
- Publication type:
- Article
Persistence of humoral response upon SARS‐CoV‐2 infection.
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 2, p. 1, doi. 10.1002/rmv.2272
- By:
- Publication type:
- Article
Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28233-8
- By:
- Publication type:
- Article
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 23/24, p. 1265, doi. 10.1007/s00508-021-01985-x
- By:
- Publication type:
- Article
Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 23/24, p. 1272, doi. 10.1007/s00508-021-01963-3
- By:
- Publication type:
- Article
Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 10, p. 1, doi. 10.1371/journal.ppat.1009996
- By:
- Publication type:
- Article
Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25506-6
- By:
- Publication type:
- Article
Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 611, doi. 10.3390/vaccines9060611
- By:
- Publication type:
- Article
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 7/8, p. 351, doi. 10.1007/s00508-020-01795-7
- By:
- Publication type:
- Article
Comparison of Four SARS-CoV-2 Neutralization Assays.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 13, doi. 10.3390/vaccines9010013
- By:
- Publication type:
- Article
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02941
- By:
- Publication type:
- Article
The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 11, p. 989, doi. 10.3390/v11110989
- By:
- Publication type:
- Article
The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1958, doi. 10.1002/ijc.32325
- By:
- Publication type:
- Article
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 59, doi. 10.3390/vaccines7030059
- By:
- Publication type:
- Article
Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 119, doi. 10.3390/vaccines7030119
- By:
- Publication type:
- Article
Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 159, doi. 10.3390/v11020159
- By:
- Publication type:
- Article
Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 7, p. 1786, doi. 10.1002/ijc.31556
- By:
- Publication type:
- Article
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 3, p. 108, doi. 10.3390/v10030108
- By:
- Publication type:
- Article
Comparison of three humanized mouse models for adoptive T cell transfer.
- Published in:
- Journal of Gene Medicine, 2012, v. 14, n. 8, p. 540, doi. 10.1002/jgm.2652
- By:
- Publication type:
- Article
Lens Epithelium-derived Growth Factor/p75 Qualifies as a Target for HIV Gene Therapy in the NSG Mouse Model.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 5, p. 908, doi. 10.1038/mt.2012.6
- By:
- Publication type:
- Article
Retroviral Insertional Mutagenesis Can Contribute to Immortalization of Mature T Lymphocytes.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 11/12, p. 1223, doi. 10.2119/molmed.2010.00193
- By:
- Publication type:
- Article
Secreted Antiviral Entry Inhibitory (SAVE) Peptides for Gene Therapy of HIV Infection.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 7, p. 1236, doi. 10.1038/mt.2011.30
- By:
- Publication type:
- Article
Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012357
- By:
- Publication type:
- Article